1. AB0274 Impact of Baseline Anti-Cyclic Citrullinated Peptide 2 Antibody Titre on Efficacy Outcomes Following Treatment with Subcutaneous Abatacept or Adalimumab: 2-Year Results from the Ample Trial. (9th June 2015) Authors: Sokolove, J.; Schiff, M.; Fleischmann, R.; Weinblatt, M.E.; Connolly, S.E.; Johnsen, A.; Zhu, J.; Maldonado, M.A.; Patel, S.; Robinson, W.H. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 983 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. FRI0019 Clinical Responses by Baseline RA Disease Duration in the AMPLE (Abatacept Versus Adalimumab Comparison in Biologic-Naïve RA Patients with Background Methotrexate) Trial: 2-Year Results. (10th June 2014) Authors: Schiff, M.; Weinblatt, M.E.; Valente, R.; van der Heijde, D.; Citera, G.; Maldonado, M.A.; Fay, J.; Fleischmann, R. Journal: Annals of the rheumatic diseases Issue: Volume 73:Supplement 2(2014) Page Start: 387 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. OP0253 A phase iii randomised, double-blind, placebo-controlled study to evaluate the efficacy and safety of abatacept or placebo on standard of care in patients with active class iii or iv lupus nephritis. (12th June 2018) Authors: Furie, R.; Dooley, M.A.; Wofsy, D.; Takeuchi, T.; Malvar, A.; Doria, A.; Romero-Díaz, J.; Chan, T.M.; Elegbe, A.; Appel, G.B.; Jayne, D.; Maldonado, M.A. Journal: Annals of the rheumatic diseases Issue: Volume 77(2018)Supplement 2 Page Start: 176 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. SAT0074 Effect of Baseline Anti-Cyclic Citrullinated Peptide 2 Antibody Titre on Patient-Reported Outcomes Following Treatment with Subcutaneous Abatacept or Adalimumab. (9th June 2015) Authors: Sokolove, J.; Schiff, M.; Fleischmann, R.; Weinblatt, M.E.; Strand, V.; Connolly, S.E.; Maldonado, M.A.; Patel, S.; Alemao, E.; Robinson, W.H. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 675 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. SAT0153 Abatacept plus Methotrexate Can Effectively and Safely Regain The Target of Remission Following Re-Treatment for Flares after Drug-Free Withdrawal in Patients with Early Rheumatoid Arthritis. (15th July 2016) Authors: Emery, P.; Burmester, G.; Bykerk, V.; Combe, B.; Furst, D.E.; Maldonado, M.A.; Huizinga, T.W. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 720 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗